SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,380 | -58.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $5,670 | +1.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $5,600 | -6.7% | 1,000 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $6,000 | +100.0% | 1,000 | 0.0% | 0.01% | +150.0% |
| Q2 2022 | $3,000 | -57.1% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $7,000 | -12.5% | 1,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $8,000 | +14.3% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $7,000 | -70.8% | 1,000 | 0.0% | 0.00% | -73.3% |
| Q2 2021 | $24,000 | +14.3% | 1,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $21,000 | -16.0% | 1,000 | 0.0% | 0.02% | -16.7% |
| Q4 2020 | $25,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |